Rare cancer survival predictor developed

NCT ID NCT07179341

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looked at 156 patients with thymic carcinoma, a rare and aggressive chest cancer. Researchers created a tool called a nomogram that uses patient data to predict how long someone might live after diagnosis. The tool was tested on three groups of patients and showed promise in estimating survival, but it needs more research before it can be used in clinics.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this tool could help doctors better predict survival for thymic carcinoma patients, guiding treatment decisions.

What could go wrong

This is a small, single-center study based on past data. The tool needs testing in larger, diverse groups before it can be widely used.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THYMIC CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

thymic carcinoma thymoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • 651 Dongfeng Road East, Yuexiu District, Guangzhou, P.R. China

    Guangzhou, Guangdong, China